Journal of Emergency Nursing
Volume 35, Issue 5 , Pages 437-441 , September 2009

Evaluation and Management of Hereditary Hemophilia in the Emergency Department

References 

  1. Wald DA, Alleyne P. Congenital bleeding disorders: diagnostic features and syndrome-specific management in the emergency department. Emerg Med Reports. 2001;22:81–92
  2. Mannucci PM, Tuddenham EG. The hemophiliac—from royal genes to gene therapy [published correction appears in N Engl J Med 2001;345:384]. N Engl J Med. 2001;344:1773–1779
  3. Mathew P, Bolton-Maggs PH. Hemophilia C. Available at: www.emedicine.com/PED/topic964.htmAccessed August 28, 2008
  4. Dunn AL, Abshire TC. Recent advances in the management of the child who has hemophilia. Hematol Oncol Clin North Am. 2004;18:1249–1276viii
  5. Agaliotis DP, Ozturk S. Hemophilia, overview. Available at: www.emedicine.com/med/topic3528.htmAccessed August 28, 2008
  6. Brown DL. Congenital bleeding disorders. Curr Probl Pediatr Adolesc Health Care. 2005;35:38–62
  7. Hemphill RR. Hematologic emergencies and life-threatening bleeding disorders: differential diagnosis, evaluation, and management—part II. Emerg Med Reports. 2001;22:191–200
  8. Sadowitz PD, Amanullah S, Souid AK. Hematologic emergencies in the pediatric emergency room. Emerg Med Clin North Am. 2002;20:177–198vii
  9. White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J Factor VIII and Factor IX Subcommittee. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85:560
  10. Balak N, Silav G, Kilic Y, Timur C, Elmaci I. Successful surgical treatment of a hemophilia infant with nontraumatic acute subdural hematoma. Surg Neurol. 2007;68:537–540
  11. Kessler CM. Hemorrhagic disorders: coagulation factor deficiencies. In:  Goldman L,  Ausiello DA,  Arend W,  Armitage JO,  Clemmons D,  Drazen J, et al. editor. Cecil medicine. 23rd ed.. Philadelphia: Saunders; 2007;
  12. Allen GA, Glader B. Approach to the bleeding child. Pediatr Clin North Am. 2002;49:1239–1256
  13. Hoyer LW. Hemophilia A. N Engl J Med. 1994;330:38–47
  14. Dunn AL. Management and prevention of recurrent hemarthrosis in patients with hemophilia. Curr Opin Hematol. 2005;12:390–394
  15. Mittal R, Spero JA, Lewis JH, Taylor F, Ragni MV, Bontempo FA, et al. Patterns of gastrointestinal hemorrhage in hemophilia. Gastroenterology. 1985;88:515–522
  16. Pierce GF, Lillicrap D, Pipe SW, Vandendriessche T. Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment. J Thromb Haemost. 2007;5:901–906
  17. National Hemophilia Foundation. MASAC document #175. Guidelines for emergency department management of individuals with hemophilia. Available at: www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=691Accessed August 28, 2008
  18. Manno CS, Larson PJ. Transfusion therapy for coagulation factor deficiencies. In: Hoffman: hematology: basic principles and practice. 4th ed. Chapter 144. Philadelphia: Elsevier; 2005.
  19. Ghosh K, Shetty S, Jinjina F, Mohanty D. Role of epsilon amino caproic acid in the management of haemophiliac patients with inhibitors. Haemophilia. 2004;10:58–62
  20. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57:1005–1032
  21. Rodriguez NI, Hoots WK. Advances in hemophilia: experimental aspects and therapy. Pediatr Clin North Am. 2008;55:357–376
  22. Kempton CL, Escobar MA, Roberts HR. Hemophilia care in the 21st century. Clin Adv Hematol Oncol. 2004;2:733–740
  23. Ananyeva NM, Lacroix-Desmazes S, Hauser CA, Shima M, Ovanesov MV, Khrenov AV, et al. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives. Blood Coagul Fibrinolysis. 2004;15:109–124
  24. Key NS. Inhibitors in congenital coagulation disorders. Br J Haematol. 2004;127:379–391
  25. Rodriguez-Merchan MC. Haemophilic synovitis: basic concepts. Haemophilia. 2007;13:1–3
  26. NovoSeven dosage and administration. Hemophilia A or B patients with inhibitors. Available at: http://www.novosevenrt.com/pdfs/PI_novosevenrt.pdfAccessed August 28, 2008

 Earn Up to 6.5 CE Hours. See page 492.

PII: S0099-1767(08)00517-5

doi: 10.1016/j.jen.2008.09.009

Journal of Emergency Nursing
Volume 35, Issue 5 , Pages 437-441 , September 2009

Article Tools